Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00065533
Status:
COMPLETED
Last Update Posted:
2007-06-22
First Post:
2003-07-28
Brief Title:
Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
Keywords: